MyAverix Finance MyAverix Finance

BA · Healthcare

Laboratorios Richmond SACIF (RICH)

Drug Manufacturers - Specialty & Generic

Laboratorios Richmond SACIF (RICH) is listed on BA in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-24

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for RICH

P/E ratio
18.00

Laboratorios Richmond SACIF (RICH) — FAQ

What is RICH's P/E ratio?

The price-to-earnings (P/E) ratio for Laboratorios Richmond SACIF (RICH) is 18.00 (data as of 2026-05-24).

Does Laboratorios Richmond SACIF pay a dividend?

Dividend yield is not available in the current snapshot for Laboratorios Richmond SACIF (RICH). Check the MyAverix Finance app for the latest dividend data.

What sector is Laboratorios Richmond SACIF in?

Laboratorios Richmond SACIF (RICH) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is RICH listed on?

RICH is listed on BA.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play